{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:23:07Z","timestamp":1787840587622,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ejon.2007.07.002","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T07:29:19Z","timestamp":1188977359000},"page":"S28-S31","source":"Crossref","is-referenced-by-count":48,"special_numbering":"S2","title":["Burden of bone disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Nicole","family":"Kinnane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2007.07.002_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005178","article-title":"Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer","volume":"005178","author":"Ballantyne","year":"2005","journal-title":"The Cochrane Database Systematic Reviews, CD"},{"key":"10.1016\/j.ejon.2007.07.002_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","article-title":"Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. For the myeloma aredia study group","volume":"16","author":"Berenson","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ejon.2007.07.002_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(05)67149-2","article-title":"Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline","volume":"164","author":"Berruti","year":"2000","journal-title":"Journal of Urology"},{"key":"10.1016\/j.ejon.2007.07.002_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/106002809603000514","article-title":"Acute management of cancer-related hypercalcemia","volume":"30","author":"Chisholm","year":"1996","journal-title":"Annals of Pharmacotherapy"},{"issue":"suppl","key":"10.1016\/j.ejon.2007.07.002_bib5","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejon.2007.07.002_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treatment Reviews"},{"issue":"suppl","key":"10.1016\/j.ejon.2007.07.002_bib7","first-page":"iii124","article-title":"Zoledronic acid is superior to pamidronate in patients with breast cancer and multiple myeloma: analysis of patients at high risk for skeletal complications","volume":"15","author":"Conte","year":"2004","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.ejon.2007.07.002_bib8","series-title":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Version 2.0","author":"Ferlay","year":"2004"},{"key":"10.1016\/j.ejon.2007.07.002_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cncr.22427","article-title":"Chemotherapy for metastatic melanoma: time for a change?","volume":"109","author":"Gogas","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejon.2007.07.002_bib10","unstructured":"Hei, Y.-J., Saad, F., Coleman, R.E., Chen, Y.-M., 2005. Fractures negatively affect survival in patients with bone metastases from breast cancer. Presented at: the 28th Annual San Antonio Breast Cancer Symposium, 8\u201311 December 2005, San Antonio, Texas. Abstract 6036."},{"key":"10.1016\/j.ejon.2007.07.002_bib11","first-page":"1873","article-title":"Treatment of oncologic emergencies","volume":"74","author":"Higdon","year":"2006","journal-title":"American Family Physician"},{"key":"10.1016\/j.ejon.2007.07.002_bib12","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.2001.19.9.2527","article-title":"Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer","volume":"19","author":"Hussain","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl","key":"10.1016\/j.ejon.2007.07.002_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0093-7754(01)90229-5","article-title":"Bone metastases: approaches to management","volume":"28","author":"Janjan","year":"2001","journal-title":"Seminars in Oncology"},{"key":"10.1016\/j.ejon.2007.07.002_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/clon.2002.0098","article-title":"Don\u2019t wait for a sensory level-listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression","volume":"14","author":"Levack","year":"2002","journal-title":"Clinical Oncology"},{"issue":"Suppl","key":"10.1016\/j.ejon.2007.07.002_bib15","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1668::AID-CNCR17>3.0.CO;2-Y","article-title":"Bisphosphonates and breast carcinoma","volume":"80","author":"Lipton","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejon.2007.07.002_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/14728214.8.2.469","article-title":"Bisphosphonate therapy in the oncology setting","volume":"8","author":"Lipton","year":"2003","journal-title":"Expert Opinion on Emerging Drugs"},{"issue":"Suppl. 2","key":"10.1016\/j.ejon.2007.07.002_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1081\/CNV-120014886","article-title":"The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate","volume":"20","author":"Lipton","year":"2002","journal-title":"Cancer Investigation"},{"key":"10.1016\/j.ejon.2007.07.002_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/annonc\/mdf017","article-title":"Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial","volume":"13","author":"Pectasides","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.ejon.2007.07.002_bib19","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","article-title":"Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial\u2014the Zoledronic acid lung cancer and other solid tumors study group","volume":"21","author":"Rosen","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"suppl","key":"10.1016\/j.ejon.2007.07.002_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eursup.2006.02.027","article-title":"Impact of bone metastases on patient's quality of life and importance of treatment","volume":"5","author":"Saad","year":"2006","journal-title":"European Urology"},{"issue":"Suppl","key":"10.1016\/j.ejon.2007.07.002_bib21","first-page":"394","article-title":"Zoledronic acid is well tolerated for up to 24 months and significantly reduces skeletal complications in patients with advanced prostate cancer metastatic to bone","volume":"169","author":"Saad","year":"2003","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.ejon.2007.07.002_bib22","first-page":"895","article-title":"Therapy of metastatic bone pain","volume":"42","author":"Serafini","year":"2001","journal-title":"Journal of Nuclear Medicine"},{"issue":"suppl","key":"10.1016\/j.ejon.2007.07.002_bib23","first-page":"630","article-title":"Long-term efficacy and safety of zoledronic acid in reducing skeletal complications in patients with bone metastases from solid tumors","volume":"22","author":"Tchekmedyian","year":"2003","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejon.2007.07.002_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/annonc\/mdi122","article-title":"The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer","volume":"16","author":"Weinfurt","year":"2005","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.ejon.2007.07.002_bib25","first-page":"379","article-title":"The skeletal metastatic complications of renal cell carcinoma","volume":"19","author":"Zekri","year":"2001","journal-title":"International Journal of Oncology"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388907000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388907000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T14:21:18Z","timestamp":1546611678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388907000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":25,"alternative-id":["S1462388907000920"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2007.07.002","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}